Equine oocyte maturation with epidermal growth factor

P. L. Lorenzo, Irwin Liu, G. F. Carneiro, Alan J Conley, A. C. Enders

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Epidermal growth factor (EGF) has been shown to have a positive effect during oocyte in vitro maturation in several species. This study was performed to establish the capacity of equine oocytes to undergo nuclear maturation in the presence of EGF and to localise its receptor in the equine ovary by immunohistochemical methods. Oocytes were obtained by aspiration and subsequent scraping from equine follicles (15-25 mm diameter) and cultured in 3 different treatment groups for 36 h: control Group (modified TCM 199 with 0.003% BSA), EGF Group (TCM-199 supplemented with 50 ng/ml EGF) and EMS Group (TCM 199 supplemented with 10% v/v oestrous mare serum). Each group was divided further into 3 treatments with tyrphostin A-47, a specific tyrosine kinase inhibitor, at 0, 10-4 and 10-6 mmol/l. Maturation was determined as the percentage of oocytes reaching metaphase II stage at the end of the culture period. Immunohistochemical detection of EGF-receptor (EGFR) was performed using a streptoavidinbiotin method. The recovery rate and oocyte retrieval were 84.6% (recovered oocytes/follicles aspirated) and 6.55 (oocytes/mare), respectively. Treatment with EGF significantly (P<0.05) increased the incidence of metaphase II stage compared with the control group (69.4 vs. 26.9% in controls, respectively). The specific-tyrosine kinase inhibitor A-47 was effective in suppressing EGF-effect on EGF-cultured oocytes; no significant differences were observed in EMS-supplemented oocytes when cultured with A-47. EGF-receptor was localised in follicles, with localisation being more prominent in the cumulus than in mural granulosa cells. This finding, together with the increase of oocyte nuclear maturation rate when using EGF in culture media and the inhibition of maturation by tyrphostin A-47, suggests a physiological role for EGF in the regulation of equine oocyte maturation. The results should help successful development of assisted reproductive technology in the horse.

Original languageEnglish (US)
Pages (from-to)378-382
Number of pages5
JournalEquine Veterinary Journal
Volume34
Issue number4
StatePublished - Jul 2002

Fingerprint

epidermal growth factor
Epidermal Growth Factor
Horses
Oocytes
oocytes
horses
Metaphase
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
metaphase
mares
tyrosine
In Vitro Oocyte Maturation Techniques
phosphotransferases (kinases)
Oocyte Retrieval
Control Groups
Assisted Reproductive Techniques
Granulosa Cells
assisted reproductive technologies
granulosa cells

Keywords

  • EGF
  • EGFR
  • Horse
  • Mare
  • Maturation
  • Oocyte

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Lorenzo, P. L., Liu, I., Carneiro, G. F., Conley, A. J., & Enders, A. C. (2002). Equine oocyte maturation with epidermal growth factor. Equine Veterinary Journal, 34(4), 378-382.

Equine oocyte maturation with epidermal growth factor. / Lorenzo, P. L.; Liu, Irwin; Carneiro, G. F.; Conley, Alan J; Enders, A. C.

In: Equine Veterinary Journal, Vol. 34, No. 4, 07.2002, p. 378-382.

Research output: Contribution to journalArticle

Lorenzo, PL, Liu, I, Carneiro, GF, Conley, AJ & Enders, AC 2002, 'Equine oocyte maturation with epidermal growth factor', Equine Veterinary Journal, vol. 34, no. 4, pp. 378-382.
Lorenzo, P. L. ; Liu, Irwin ; Carneiro, G. F. ; Conley, Alan J ; Enders, A. C. / Equine oocyte maturation with epidermal growth factor. In: Equine Veterinary Journal. 2002 ; Vol. 34, No. 4. pp. 378-382.
@article{f830541cdd644d3c9d36d71060123455,
title = "Equine oocyte maturation with epidermal growth factor",
abstract = "Epidermal growth factor (EGF) has been shown to have a positive effect during oocyte in vitro maturation in several species. This study was performed to establish the capacity of equine oocytes to undergo nuclear maturation in the presence of EGF and to localise its receptor in the equine ovary by immunohistochemical methods. Oocytes were obtained by aspiration and subsequent scraping from equine follicles (15-25 mm diameter) and cultured in 3 different treatment groups for 36 h: control Group (modified TCM 199 with 0.003{\%} BSA), EGF Group (TCM-199 supplemented with 50 ng/ml EGF) and EMS Group (TCM 199 supplemented with 10{\%} v/v oestrous mare serum). Each group was divided further into 3 treatments with tyrphostin A-47, a specific tyrosine kinase inhibitor, at 0, 10-4 and 10-6 mmol/l. Maturation was determined as the percentage of oocytes reaching metaphase II stage at the end of the culture period. Immunohistochemical detection of EGF-receptor (EGFR) was performed using a streptoavidinbiotin method. The recovery rate and oocyte retrieval were 84.6{\%} (recovered oocytes/follicles aspirated) and 6.55 (oocytes/mare), respectively. Treatment with EGF significantly (P<0.05) increased the incidence of metaphase II stage compared with the control group (69.4 vs. 26.9{\%} in controls, respectively). The specific-tyrosine kinase inhibitor A-47 was effective in suppressing EGF-effect on EGF-cultured oocytes; no significant differences were observed in EMS-supplemented oocytes when cultured with A-47. EGF-receptor was localised in follicles, with localisation being more prominent in the cumulus than in mural granulosa cells. This finding, together with the increase of oocyte nuclear maturation rate when using EGF in culture media and the inhibition of maturation by tyrphostin A-47, suggests a physiological role for EGF in the regulation of equine oocyte maturation. The results should help successful development of assisted reproductive technology in the horse.",
keywords = "EGF, EGFR, Horse, Mare, Maturation, Oocyte",
author = "Lorenzo, {P. L.} and Irwin Liu and Carneiro, {G. F.} and Conley, {Alan J} and Enders, {A. C.}",
year = "2002",
month = "7",
language = "English (US)",
volume = "34",
pages = "378--382",
journal = "Equine veterinary journal. Supplement",
issn = "2042-3306",
publisher = "British Equine Veterinary Association",
number = "4",

}

TY - JOUR

T1 - Equine oocyte maturation with epidermal growth factor

AU - Lorenzo, P. L.

AU - Liu, Irwin

AU - Carneiro, G. F.

AU - Conley, Alan J

AU - Enders, A. C.

PY - 2002/7

Y1 - 2002/7

N2 - Epidermal growth factor (EGF) has been shown to have a positive effect during oocyte in vitro maturation in several species. This study was performed to establish the capacity of equine oocytes to undergo nuclear maturation in the presence of EGF and to localise its receptor in the equine ovary by immunohistochemical methods. Oocytes were obtained by aspiration and subsequent scraping from equine follicles (15-25 mm diameter) and cultured in 3 different treatment groups for 36 h: control Group (modified TCM 199 with 0.003% BSA), EGF Group (TCM-199 supplemented with 50 ng/ml EGF) and EMS Group (TCM 199 supplemented with 10% v/v oestrous mare serum). Each group was divided further into 3 treatments with tyrphostin A-47, a specific tyrosine kinase inhibitor, at 0, 10-4 and 10-6 mmol/l. Maturation was determined as the percentage of oocytes reaching metaphase II stage at the end of the culture period. Immunohistochemical detection of EGF-receptor (EGFR) was performed using a streptoavidinbiotin method. The recovery rate and oocyte retrieval were 84.6% (recovered oocytes/follicles aspirated) and 6.55 (oocytes/mare), respectively. Treatment with EGF significantly (P<0.05) increased the incidence of metaphase II stage compared with the control group (69.4 vs. 26.9% in controls, respectively). The specific-tyrosine kinase inhibitor A-47 was effective in suppressing EGF-effect on EGF-cultured oocytes; no significant differences were observed in EMS-supplemented oocytes when cultured with A-47. EGF-receptor was localised in follicles, with localisation being more prominent in the cumulus than in mural granulosa cells. This finding, together with the increase of oocyte nuclear maturation rate when using EGF in culture media and the inhibition of maturation by tyrphostin A-47, suggests a physiological role for EGF in the regulation of equine oocyte maturation. The results should help successful development of assisted reproductive technology in the horse.

AB - Epidermal growth factor (EGF) has been shown to have a positive effect during oocyte in vitro maturation in several species. This study was performed to establish the capacity of equine oocytes to undergo nuclear maturation in the presence of EGF and to localise its receptor in the equine ovary by immunohistochemical methods. Oocytes were obtained by aspiration and subsequent scraping from equine follicles (15-25 mm diameter) and cultured in 3 different treatment groups for 36 h: control Group (modified TCM 199 with 0.003% BSA), EGF Group (TCM-199 supplemented with 50 ng/ml EGF) and EMS Group (TCM 199 supplemented with 10% v/v oestrous mare serum). Each group was divided further into 3 treatments with tyrphostin A-47, a specific tyrosine kinase inhibitor, at 0, 10-4 and 10-6 mmol/l. Maturation was determined as the percentage of oocytes reaching metaphase II stage at the end of the culture period. Immunohistochemical detection of EGF-receptor (EGFR) was performed using a streptoavidinbiotin method. The recovery rate and oocyte retrieval were 84.6% (recovered oocytes/follicles aspirated) and 6.55 (oocytes/mare), respectively. Treatment with EGF significantly (P<0.05) increased the incidence of metaphase II stage compared with the control group (69.4 vs. 26.9% in controls, respectively). The specific-tyrosine kinase inhibitor A-47 was effective in suppressing EGF-effect on EGF-cultured oocytes; no significant differences were observed in EMS-supplemented oocytes when cultured with A-47. EGF-receptor was localised in follicles, with localisation being more prominent in the cumulus than in mural granulosa cells. This finding, together with the increase of oocyte nuclear maturation rate when using EGF in culture media and the inhibition of maturation by tyrphostin A-47, suggests a physiological role for EGF in the regulation of equine oocyte maturation. The results should help successful development of assisted reproductive technology in the horse.

KW - EGF

KW - EGFR

KW - Horse

KW - Mare

KW - Maturation

KW - Oocyte

UR - http://www.scopus.com/inward/record.url?scp=0036633568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036633568&partnerID=8YFLogxK

M3 - Article

C2 - 12117110

AN - SCOPUS:0036633568

VL - 34

SP - 378

EP - 382

JO - Equine veterinary journal. Supplement

JF - Equine veterinary journal. Supplement

SN - 2042-3306

IS - 4

ER -